Clinical Trials Directory

Trials / Completed

CompletedNCT01529346

Efficacy Of PF-05089771 In Treating Postoperative Dental Pain

A Randomized, Double-blind, Double-dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of Pf-05089771 For The Treatment Of Postoperative Dental Pain Using Ibuprofen 400 Mg As Positive Control

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
235 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the overall pain relief of a single dose of PF-05089771 against placebo following third molar extraction.

Conditions

Interventions

TypeNameDescription
DRUGPF-05089771A single dose of PF-05089771 1600 mg oral solution administered once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively
DRUGPF-05089771A single dose of PF-05089771 450 mg oral solution administered once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively
DRUGPF-05089771A single dose of PF-05089771 150 mg oral solution administered once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo tablets for ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively
DRUGIbuprofen2 X 200 mg tablets of ibuprofen administered orally once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo solution for PF-05089771: A single dose of Placebo solution administered once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo solution for PF-05089771:A single dose of Placebo solution administered once to the subject on Day 1 postoperatively
OTHERPlaceboPlacebo tablets for Ibuprofen: 2 X 200 mg placebo tablets administered orally once to the subject on Day 1 postoperatively

Timeline

Start date
2011-12-12
Primary completion
2012-06-25
Completion
2012-06-25
First posted
2012-02-08
Last updated
2018-06-01
Results posted
2018-06-01

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01529346. Inclusion in this directory is not an endorsement.